Has Alan Percy received payments from drug or device companies?

Yes. Drug and device makers reported $50,653 in general payments to Alan Percy across 59 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Alan Percy did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Alan Percy come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Alan Percy

Neurology with Special Qualifications in Child Neurology · Birmingham, ALNPI 1962570614

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (55.3%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Acadia Pharmaceuticals Inc accounts for 94.9% of it on its own, with 3 other manufacturers making up the rest. Among neurology with special qualifications in child neurology clinicians in AL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$50,653in general payments, 2019–2025

Across 59 payments — averaging $858.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Acadia Pharmaceuticals Inc$48K
GW Research Limited$1K
Ionis Pharmaceuticals, Inc.$1K
Astellas Pharma US Inc$37

$434,181in research payments, 2019–2025

Across 58 payments — averaging $7485.88 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Acadia Pharmaceuticals Inc$381K
GW Research Limited$53K

What the payments were for

Consulting fees$17,88335%
Speaking & faculty fees$28,02555%
Travel & lodging$3,6537%
Food & beverage$1,0722%
Education$200%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Acadia Pharmaceuticals Inc	51	$48,074
GW Research Limited	6	$1,442
Ionis Pharmaceuticals, Inc.	1	$1,100
Astellas Pharma US Inc	1	$37

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

DAYBUE$40,166
NUPLAZID$4,557

How this compares

$50,653 in reported general payments places this provider in the 95th percentile of 24 neurology with special qualifications in child neurology providers in Alabama.

See all neurology with special qualifications in child neurology providers in Alabama →

Other neurology with special qualifications in child neurology in Birmingham

Alyssa ReddyBirmingham$68K
Michael LopezBirmingham$22K
Elizabeth BebinBirmingham$15K
Amitha AnanthBirmingham$10K
Jan MathisenBirmingham$8K
Monisha GoyalBirmingham$8K
Kathryn LalorBirmingham$3K
Pongkiat KankirawatanaBirmingham$2K
Emily GantzBirmingham$1K
Katherine ThaggardBirmingham$1K

See the full list for Alabama →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →